» Articles » PMID: 22297824

Molecular Weight Effects on the Miscibility Behavior of Dextran and Maltodextrin with Poly(vinylpyrrolidone)

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 2012 Feb 3
PMID 22297824
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To characterize and interpret the miscibility of dextran and maltodextrin with poly(vinylpyrrolidone) (DEX-PVP) as a function of polymer molecular weights.

Methods: Blend miscibility was studied using 4 different molecular weight (MW) grades of DEX combined with 5 MW grades of PVP, over a broad compositional range. Miscibility was evaluated by inspection of glass transition events measured by differential scanning calorimetry (DSC). Fourier transform mid-infrared spectroscopy (FTIR), combined with curve fitting, was performed to characterize the extent of hydrogen bonding. The observed miscibility behavior was further interpreted in terms of mixing thermodynamics.

Results: Miscibility of the blends ranged from fully miscible to completely immiscible with multiple partially miscible systems observed. Increasing polymer molecular weight decreased miscibility. For the lowest DEX grade, hydrogen bonding was independent of PVP MW, as expected since all systems were completely miscible. Higher molecular weights of DEX resulted in reduced intermolecular hydrogen bonding and decreased miscibility, increasingly so for higher MW PVP grades. Evaluation of the mixing thermodynamics supported these findings.

Conclusions: With higher combined molecular weights of DEX-PVP blends, phase behavior evolves from completely miscible to virtually immiscible. Concurrently, DEX-PVP hydrogen bonding decreases. From a thermodynamic perspective, the combinatorial mixing entropy was observed to decrease as the molecular weight of the polymers increased, providing a reduced counterbalance to the unfavorable mixing enthalpy thought to accompany this polymer combination.

References
1.
Van Eerdenbrugh B, Taylor L . Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation. Mol Pharm. 2010; 7(4):1328-37. DOI: 10.1021/mp1001153. View

2.
Qi S, Belton P, Nollenberger K, Clayden N, Reading M, Craig D . Characterisation and prediction of phase separation in hot-melt extruded solid dispersions: a thermal, microscopic and NMR relaxometry study. Pharm Res. 2010; 27(9):1869-83. DOI: 10.1007/s11095-010-0185-8. View

3.
Baird J, Taylor L . Evaluation of amorphous solid dispersion properties using thermal analysis techniques. Adv Drug Deliv Rev. 2011; 64(5):396-421. DOI: 10.1016/j.addr.2011.07.009. View

4.
Rumondor A, Ivanisevic I, Bates S, Alonzo D, Taylor L . Evaluation of drug-polymer miscibility in amorphous solid dispersion systems. Pharm Res. 2009; 26(11):2523-34. DOI: 10.1007/s11095-009-9970-7. View

5.
Izutsu K, Aoyagi N, Kojima S . Effect of polymer size and cosolutes on phase separation of poly(vinylpyrrolidone) (PVP) and dextran in frozen solutions. J Pharm Sci. 2005; 94(4):709-17. DOI: 10.1002/jps.20292. View